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============

The mammalian reoviruses are members of the *Reoviridae* family, which includes the important human pathogens rotavirus and Colorado-tick fever virus (Schiff et al. [@CR120_32]). Like other *Reoviridae* members, reoviruses are nonenveloped, icosahedral particles that contain a segmented, double-stranded (ds) RNA genome surrounded by concentric protein shells (Schiff et al. [@CR120_32]). These viruses are ubiquitous and display a broad host range, resulting in infection of wide variety of mammals including humans (Virgin et al. [@CR142_32]). However, reovirus causes disease primarily in the very young (Mann et al. [@CR90_32]; Tardieu et al. [@CR133_32]; Tyler et al. [@CR139_32]). These viruses have served in some respects as prototypes for the study of the *Reoviridae* due to the availability of isolates that display dissimilar phenotypes, the ability to perform genetic analysis using reassortant viruses and reverse genetics, and the existence of a murine model of virus-induced disease.

Initiation of reovirus infection requires deposition of the genome-containing inner capsid (known as the core) into the cytoplasm. Delivery of this rather large cargo (∼70 nm in diameter) requires an exquisitely timed and regulated series of events both at the host cell surface and within host endosomes. The virus must attach to host cells, internalize and traffic to cellular endosomes, undergo proteolytic disassembly to expose the viral membrane-penetration apparatus, and penetrate host cell membranes for delivery of the viral core into the cytoplasm. These early events during reovirus infection activate innate immune signaling pathways. Here, we describe our current understanding of each of these steps in the cell entry pathway used by reovirus.

Structural Analysis of Reovirus Virions and Attachment Protein σ1 {#Sec2}
=================================================================

Reovirus particles are approximately 850 Å in diameter and consist of two concentric protein shells, the inner core and outer capsid (Dryden et al. [@CR49_32]; Schiff et al. [@CR120_32]) (Fig. [1](#Fig1){ref-type="fig"}). The reovirus genome consists of ten segments of dsRNA, which range in length from ∼1.2 to ∼3.9 kilobases. The genome segments are named based on size, with three large (L), three medium (M), and four small (S) segments. Reovirus proteins are designated according to the encoding gene segments, *lambda* (λ) for L, *mu* (μ) for M, and *sigma* (σ) for S. The reovirus inner core has *T* = 1 symmetry and is primarily formed by a shell of 60 asymmetric dimers of λ1 and 150 monomers of σ2 (Reinisch et al. [@CR115_32]). Pentameric turrets of λ2, a capping enzyme and conduit for viral transcripts exiting the core, are located at the icosahedral vertices of the reovirus particle and span both the inner core and the outer capsid (Bartlett et al. [@CR7_32]; Cleveland et al. [@CR33_32]; Dryden et al. [@CR49_32]; Fausnaugh and Shatkin [@CR55_32]; Furuichi et al. [@CR60_32]; Gillies et al. [@CR63_32]; Luongo et al. [@CR86_32], [@CR87_32]; Mao and Joklik [@CR91_32]; Reinisch et al. [@CR115_32]). Minor core components include μ2 (∼24 copies) and λ3 (12 copies) (Coombs [@CR39_32]; Dryden et al. [@CR50_32]). Each copy of viral RNA-dependent RNA polymerase λ3 is associated with three monomers of λ1 and occupies a single icosahedral vertex in the inner core (Drayna and Fields [@CR48_32]; Starnes and Joklik [@CR124_32]; Tao et al. [@CR132_32]; Zhang et al. [@CR153_32]). Surrounding the core is the outer capsid, which has quasi *T* = 13 (*laevo*) icosahedral symmetry (Metcalf [@CR96_32]) and is composed of 200 heterohexamers of the membrane-penetration protein, μ1, and its protective cap, σ3 (μ1~3~σ3~3~) (Dryden et al. [@CR49_32]; Liemann et al. [@CR84_32]; Metcalf [@CR96_32]). Extending from a λ2 turret at each vertex of a reovirus particle is a trimer of σ1, the viral attachment protein, which is released during entry (Chappell et al. [@CR30_32]; Dryden et al. [@CR49_32]; Fraser et al. [@CR58_32]; Furlong et al. [@CR59_32]; Strong et al. [@CR129_32]).Fig. 1Reovirus disassembly intermediates. Surface-shaded representations of cryo-EM image reconstructions of reovirus are shown, as viewed along a twofold axis of symmetry. Density corresponding to σ1 can be seen extending from turrets of λ2 at the icosahedral axes of virions and ISVPs. Cores lack σ1. Image adapted from Dryden et al. ([@CR49_32])

The reovirus σ1 protein mediates binding to cellular receptors (Barton et al. [@CR9_32]; Chappell et al. [@CR29_32]) and influences target-cell selection in the infected host (Weiner et al. [@CR144_32], [@CR145_32]). The 455 amino acids of strain T3D σ1 fold into a trimer approximately 480 Å long and 90 Å wide at its broadest point, with a globular C-terminal head, a central body, and a slender N-terminal tail (Chappell et al. [@CR30_32]; Fraser et al. [@CR58_32]; Guglielmi et al. [@CR67_32]) (Fig. [2](#Fig2){ref-type="fig"}). Residues 310--455 comprise the head, which is constructed from two Greek-key motifs that assemble into an eight-stranded β-barrel (Chappell et al. [@CR30_32]; Schelling et al. [@CR119_32]). With the exception of the loop connecting β-strands D and E (D--E loop), which contains a 3~10~ helix, loops connecting individual strands of the β-barrel are very short. N-terminal to the σ1 head, residues 246--309 form repeating units of two antiparallel β-strands connected by short loops. Three such units assemble into a triple β-spiral, which is a motif observed to date only in viral fibers, including the adenovirus fiber (van Raaij et al. [@CR141_32]), bacteriophage PRD1 P5 (Merckel et al. [@CR95_32]), avian reovirus attachment protein σC (Guardado et al. [@CR66_32]), and mammalian reovirus T3D σ1 (Chappell et al. [@CR30_32]). In addition to the three β-spiral repeats observed in the crystallized σ1 fragment, sequence analysis suggests that the remainder of the T3D σ1 body (residues 167--249) contains an additional five N-terminal β-spiral repeats (Chappell et al. [@CR30_32]; Guglielmi et al. [@CR67_32]). Alternatively, these residues may form a combination of β-spiral repeats and α-helical coiled-coil, as suggested by sequence analysis (Chappell et al. [@CR30_32]; Guglielmi et al. [@CR67_32]; Nibert et al. [@CR103_32]) and an observed narrowing in this region in a composite negative-stain electron micrograph (EM) (Fraser et al. [@CR58_32]). The structure of the N-terminal tail, residues ∼1--160, of σ1 is unknown. However, a repeating heptad sequence motif is predictive of an amphipathic α-helix, which likely assembles into an α-helical coiled-coil in the trimer (Chappell et al. [@CR30_32]; Guglielmi et al. [@CR67_32]; Nibert et al. [@CR103_32]). The extreme N-terminus of σ1 does not contain any obvious sequence motifs. It is hydrophobic and anchors the protein into the pentameric turret formed by λ2 in the reovirus virion (Dryden et al. [@CR49_32]; Furlong et al. [@CR59_32]). This symmetry mismatch suggests an interaction of limited strength, which may aid in σ1 release during viral disassembly (Stehle and Dermody [@CR125_32]).Fig. 2Model of reovirus attachment to JAM-A on the cell surface. A ribbon-trace model of full-length T3D σ1, extending from a schematic virion, with the known structure of the C-terminus (Chappell et al. [@CR30_32]) in *tricolor* and the prediction for the N-terminus in *gray*. The predicted SA-binding site (Chappell et al. [@CR29_32]; Dermody et al. [@CR45_32]) is marked with a *hexagon*. The extracellular domains D1 and D2 of JAM-A (Prota et al. [@CR113_32]) and schematic representations of the transmembrane (TM) and intracellular domains are shown in *green*. *Asterisks* indicate regions of flexibility. For clarity, only two JAM-A monomers are shown bound to σ1. Figure and legend modified from Kirchner et al. ([@CR81_32])

The σ1 molecule possesses discrete regions of flexibility along its length (Chappell et al. [@CR30_32]; Fraser et al. [@CR58_32]) (Fig. [2](#Fig2){ref-type="fig"}). One site of substantial flexibility in T3D σ1 is contributed by a four-residue insertion between the two most C-terminal β-spiral repeats (Cavalli et al. [@CR18_32]; Chappell et al. [@CR30_32]). Sequence alignments suggest that σ1 of reovirus prototype strains T1L and T2J each contain a six-residue insertion at the same position (Chappell et al. [@CR30_32]). This insertion appears to correspond to a region of flexibility observed just below the σ1 head in EM images (Fraser et al. [@CR58_32]). A second region of flexibility observed at the midpoint of σ1 may correspond to the transition between the predicted α-helical coiled-coil region of the tail and the β-spiral-containing body, and a final region of flexibility close to the N-terminus likely represents the virion insertion domain (Chappell et al. [@CR30_32]; Fraser et al. [@CR58_32]; Guglielmi et al. [@CR67_32]; Nibert et al. [@CR103_32]).

Reovirus σ1 undergoes significant conformational alterations during viral disassembly (Dryden et al. [@CR49_32]; Furlong et al. [@CR59_32]; Nibert et al. [@CR104_32]). Some serotype 3 reoviruses, including T3D, can be cleaved by intestinal proteases (Nibert et al. [@CR104_32]). Cleavage occurs in the σ1 body (Chappell et al. [@CR28_32]), just N-terminal to the first β-spiral repeat in the crystal structure (Chappell et al. [@CR30_32]). This proteolytic cleavage enhances viral hemagglutination capacity, suggesting an unmasking or conformational change in the sialic acid (SA)-binding region of the molecule (Nibert et al. [@CR104_32]). This idea is supported by the observation of σ1 molecules with either single- or multilobed head regions (Fraser et al. [@CR58_32]), which suggests that σ1 may exist in both "open" and "closed" conformations.

Although neither the precise mechanism nor the nature of σ1 conformational changes is understood, structural studies of σ1 provide clues about how these changes might occur. A cluster of six conserved aspartic acid residues on a rigid β-hairpin at the base of the σ1 head, sandwiched between hydrophobic residues that block access to solvent, forms the main contact area between monomers in the trimer (Chappell et al. [@CR30_32]; Schelling et al. [@CR119_32]). Of the two aspartic acid residues contributed by each monomer, one (Asp346) is neutralized by a salt-bridge interaction with a nearby residue, while the other (Asp345) is not (Chappell et al. [@CR30_32]; Schelling et al. [@CR119_32]). The three Asp345 side chains closely appose each other at the center of the trimer in an otherwise hydrophobic environment. Since accumulation of negative charge in this region is predicted to destabilize the trimer (Cavalli et al. [@CR18_32]), and a D345N mutation results in σ1 trimers with a structure indistinguishable from wild-type (Schelling et al. [@CR119_32]), it is likely that Asp345 is protonated in the σ1 crystal structure (Chappell et al. [@CR30_32]), representing the "closed" conformation of σ1. This conformation might form during crystallization at near-neutral pH and physiologically in conditions of low pH, similar to those encountered in the endocytic compartment during reovirus entry (Schelling et al. [@CR119_32]). Thus, the aspartic acid sandwich motif may contribute to σ1 conformational rearrangements by acting as a molecular switch that mediates the oligomeric state of the σ1 head, depending on environmental pH (Schelling et al. [@CR119_32]).

Reovirus Attachment Is Mediated by Cell-Surface Sialic Acid and Junctional Adhesion Molecule-A {#Sec3}
==============================================================================================

Similar to viruses from a broad array of families that use carbohydrates as receptors (Olofsson and Bergstrom [@CR110_32]), cell-surface SA serves as a receptor for several serotype 3 reovirus strains, including prototype strain T3D (Barton et al. [@CR8_32]; Chappell et al. [@CR29_32]; Gentsch and Pacitti [@CR61_32], [@CR62_32]; Paul et al. [@CR112_32]). T3D exhibits a reduced capacity to agglutinate erythrocytes following treatment with neuraminidase, which removes terminal SA moieties (Gentsch and Pacitti [@CR62_32]). Preincubation of either L cells with neuraminidase or virus with sialosides also significantly diminishes T3D binding (Gentsch and Pacitti [@CR61_32]; Paul et al. [@CR112_32]). SA residues linked in either α2,3 or α2,6 configurations effectively block serotype 3 reovirus binding to L cells (Paul et al. [@CR112_32]). Reovirus T3D binds to sialoglycophorin, but not to asialoglycophorin, with an avidity of ∼5 × 10^−9^ M (Barton et al. [@CR8_32]), which is a property mediated by the σ1 protein (Chappell et al. [@CR29_32]). Thus, SA functions as a serotype 3 reovirus receptor in cultured cells. In addition, SA binding also serves an important role in reovirus tropism and pathogenesis *in vivo* (Barton et al. [@CR10_32]). An SA-binding strain of reovirus, but not a non-SA-binding strain, causes bile duct injury in newborn mice and exhibits 1,000-fold greater binding capacity for human cholangiocarcinoma cells, which are derived from bile duct epithelium.

Although the structure of σ1 in complex with SA is not yet available, studies using expressed proteins indicate that the region of T3D σ1 required for SA binding resides near the midpoint of the body, while a region just N-terminal to the head domain of T1L σ1 binds carbohydrate (Chappell et al. [@CR29_32]). For both T1L and T3D, interactions with carbohydrate are mediated by a region of predicted β-spiral (Chappell et al. [@CR30_32]). The capacity to bind SA is essential for reovirus infection of murine erythroleukemia (MEL) cells (Chappell et al. [@CR27_32]; Rubin et al. [@CR117_32]). Adaptation of non-SA-binding reoviruses to growth in MEL cells results in amino acid substitutions at residues 198, 202, and 204 of σ1 that confer SA-binding capacity on the resultant viruses (Chappell et al. [@CR27_32]). Molecular modeling of the σ1 body, based on available structure and sequence data, suggests that these residues are surface-exposed and proximal to one another in the predicted β-spiral region (Chappell et al. [@CR30_32]). Thus, residues 198, 202, and 204 are likely to contribute to an SA-binding site in T3D σ1.

In addition to SA, reovirus also binds junctional adhesion molecule-A (JAM-A, also known as F11R/JAM/JAM1), a member of the immunoglobulin superfamily (Barton et al. [@CR9_32]; Martin-Padura et al. [@CR92_32]; Williams et al. [@CR149_32]). JAM-A was identified as a reovirus receptor using a genetic screen and subsequently shown to bind directly to the σ1 head domain with nanomolar affinity (Barton et al. [@CR9_32]; Schelling et al. [@CR119_32]). Human and murine homologs of JAM-A, but not JAM family members JAM-B or JAM-C, serve as receptors for all reovirus serotypes and strains tested to date (Barton et al. [@CR9_32]; Campbell et al. [@CR17_32]; Prota et al. [@CR113_32]). The role of JAM-A as a reovirus receptor *in vivo* has been examined using JAM-A-null mice (Antar et al. [@CR4_32]). Following peroral inoculation, JAM-A is dispensable for reovirus growth in the intestine. However, it is required for infection of vascular endothelial cells and promotes efficient hematogenous dissemination of reovirus to sites of secondary infection. Thus, JAM-A serves as a high-affinity reovirus receptor in cultured cells and *in vivo*.

Structural and biochemical studies highlight the regions and specific interactions that mediate reovirus engagement of JAM-A (Campbell et al. [@CR17_32]; Chappell et al. [@CR30_32]; Forrest et al. [@CR57_32]; Guglielmi et al. [@CR68_32]; Kirchner et al. [@CR81_32]; Prota et al. [@CR113_32]) (Fig. [3](#Fig3){ref-type="fig"}). The largest area of conserved residues in σ1 forms the D--E and F--G loops in the head domain (Campbell et al. [@CR17_32]; Chappell et al. [@CR30_32]). The crystal structure of the T3D σ1 head domain in complex with the JAM-A D1 domain reveals that residues in this region, centered at the D--E loop and its 3~10~ helix, form the largest area of JAM-A contact (Kirchner et al. [@CR81_32]). Interactions in this area are highly polar and involve residues Thr380, Gly381, and Asp382. A second, unpredicted area of JAM-A contact resides within the σ1 body, just N-terminal to the head domain. Interactions in this region are largely hydrophobic and involve β-spiral residues Tyr298 and Arg316, the α-helical turn that connects the β-spiral with the β-barrel, and Pro377.Fig. 3Crystal structure of the σ1-JAM-A complex. (**a** and **b**) Ribbon drawings of a complex formed between the trimeric σ1 head domain and monomeric JAM-A D1, viewed along the threefold symmetry axis (**a**) and from the side (**b**). Monomers of the σ1 head are shown in *blue*, *red*, and *yellow*; JAM-A D1 is shown in *green*. Secondary structure elements are labeled. Figure and legend modified from Kirchner et al. ([@CR81_32])

The D1 domain of JAM-A is required for high-affinity binding to σ1 (Forrest et al. [@CR57_32]; Guglielmi et al. [@CR68_32]; Prota et al. [@CR113_32]). Mutation of individual JAM-A D1 domain residues Arg59, Glu61, Lys63, Leu72, Tyr75, and Asn76, which lie in or adjacent to the dimer interface, diminishes or abolishes σ1 binding and reovirus infectivity (Guglielmi et al. [@CR68_32]). Concordantly, the structure of the σ1-JAM-A complex shows that each σ1 trimer binds three independent JAM-A monomers (Kirchner et al. [@CR81_32]). Contacts primarily involve the JAM-A dimer interface and a conserved region at the base of the σ1 head (Chappell et al. [@CR30_32]; Kirchner et al. [@CR81_32]) (Fig. [3](#Fig3){ref-type="fig"}). In addition, the structure of the σ1-JAM-A complex also identifies residues bound by σ1 that are found just outside the dimer interface of JAM-A (Kirchner et al. [@CR81_32]). These residues may serve as initial contact points for σ1 and facilitate disruption of the JAM-A homodimer to allow interaction of σ1 with the JAM-A dimer interface. It is also possible that a cavity in the JAM-A dimer interface renders the homodimer intrinsically unstable, thereby promoting its disruption by σ1. Regardless of the mechanism, the σ1-JAM-A interaction is thermodynamically favored, as the *K* ~D~ is approximately 1,000-fold lower than the *K* ~D~ of the JAM-A homodimer interaction (Guglielmi et al. [@CR68_32]; Kirchner et al. [@CR81_32]).

Reovirus employs a multistep mechanism of viral attachment in which a low-affinity interaction with SA serves to tether the virion to target cells and precedes a high-affinity interaction with JAM-A (Barton et al. [@CR8_32]). This strategy for adhesion to host cells is used by members of unrelated virus families (Berger et al. [@CR12_32]; Dragic et al. [@CR47_32]; Montgomery et al. [@CR98_32]; Ugolini et al. [@CR140_32]). In some cases, such as with HIV, initial receptor engagement leads to conformational changes in the viral attachment protein that permit coreceptor engagement (Sattentau and Moore [@CR118_32]). It is not known whether binding to SA induces structural changes in σ1, which affect its capacity to interact with JAM-A. However, it is clear that SA binding is not a necessary prerequisite for JAM-A binding, as non-SA-binding reoviruses are capable of binding JAM-A (Barton et al. [@CR9_32]).

Internalization of Reovirus Virions into the Endocytic Pathway Is Mediated by β1 Integrins {#Sec4}
==========================================================================================

Following attachment to cell-surface carbohydrate and JAM-A, reovirus is internalized by receptor-mediated endocytosis (Borsa et al. [@CR14_32], [@CR15_32]; Ehrlich et al. [@CR54_32]; Maginnis et al. [@CR88_32], [@CR89_32]; Sturzenbecker et al. [@CR130_32]) (Fig. [4](#Fig4){ref-type="fig"}). Expression of a JAM-A truncation mutant lacking a cytoplasmic tail allows reovirus to infect nonpermissive cells (Maginnis et al. [@CR88_32]), suggesting that molecules other than JAM-A mobilize the internalization apparatus that promotes reovirus cell entry. Based on similarities in the structures of the reovirus and adenovirus attachment proteins and receptors (Stehle and Dermody [@CR126_32]), it was hypothesized that reovirus and adenovirus employ similar integrin-dependent internalization mechanisms to enter cells. In keeping with this hypothesis, reovirus λ2 protein contains conserved integrin-binding motifs, RGD and KGE (Breun et al. [@CR16_32]; Seliger et al. [@CR122_32]). These sequences are displayed on surface-exposed loops of λ2 (Reinisch et al. [@CR115_32]), where they could interact with integrins. Interestingly, the λ2-encoding L2 gene segment is genetically linked to viral shedding in infected mice and spread to littermates (Keroack and Fields [@CR80_32]), suggesting a role for λ2 in reovirus-induced disease.Fig. 4The reovirus cell entry pathway. (**a**) Following attachment to cell-surface carbohydrate (α-linked sialic acid for serotype 3 reoviruses) and JAM-A, reovirus virions enter cells by receptor-mediated endocytosis. (**b**) Within the endocytic compartment, the viral outer capsid undergoes acid-dependent proteolysis. (**c**) The first disassembly intermediate is the ISVP, which is characterized by loss of σ3 and cleavage of μ1C into particle-associated fragments δ and φ. (**d**) The ISVP then undergoes further conformational changes to form the ISVP\*. The ISVP\* is characterized by conformational rearrangements of the μ1 fragments to expose hydrophobic residues, release of μ1N, and loss of attachment protein σ1. (**e**) The μ1 cleavage fragments mediate penetration through the endosomal membrane, releasing the transcriptionally active core into the cytoplasm

Treatment of cells with antibodies specific for β1 integrin reduces reovirus infection, while antibodies specific for the other integrin subunits expressed on permissive cells, including those specific for α integrin subunits, have no effect (Maginnis et al. [@CR88_32]). However, antibodies specific for β1 integrin do not alter infection by *in-vitro* generated infectious subvirion particles (ISVPs) (Maginnis et al. [@CR88_32]), which directly penetrate the plasma membrane and do not require endocytosis (Hooper and Fields [@CR74_32]; Lucia-Jandris et al. [@CR85_32]). These findings suggest that β1 integrin blockade inhibits endocytic uptake of virions. In comparison to β1 integrin-expressing cells, β1-null cells are substantially less susceptible to infection by reovirus virions, while infection by ISVPs is equivalent in both cell types (Maginnis et al. [@CR88_32]). Diminished reovirus replication in β1-null cells correlates with diminished viral uptake (Fig. [5](#Fig5){ref-type="fig"}), indicating that β1 integrin is required for efficient reovirus cell entry.Fig. 5β1 Integrin enhances reovirus entry into cells. GD25 (β1^−/−^) and GD25β1A (β1^+/+^) cells were chilled, adsorbed with strain T1L virions, and incubated at 4°C for 1 h. Nonadherent virus was removed, warm medium was added, and cells were incubated at 37°C for the times shown. Cells were fixed, stained for reovirus (*green*), actin (*red*), and DNA (*blue*), and imaged using confocal immunofluorescence microscopy. Representative digital fluorescence images of the same field are shown in each row. Figure and legend modified from Maginnis et al. ([@CR88_32])

Most available evidence suggests that reovirus is internalized by a clathrin-dependent pathway (Borsa et al. [@CR14_32], [@CR15_32]; Ehrlich et al. [@CR54_32]; Maginnis et al. [@CR89_32]; Sturzenbecker et al. [@CR130_32]). Reovirus virions are observed to colocalize with clathrin in living cells (Ehrlich et al. [@CR54_32]), and treatment of cells with chlorpromazine, a clathrin-specific chemical inhibitor, inhibits reovirus internalization and infection (Maginnis et al. [@CR89_32]). However, both clathrin- and caveolin-dependent mechanisms can be employed by some viruses to enter host cells (Laniosz et al. [@CR83_32]; Querbes et al. [@CR114_32]). Although there are no published reports of clathrin-independent uptake strategies for reovirus, a role for caveolae in reovirus cell entry has not been conclusively excluded.

NPXY motifs in the β1 integrin cytoplasmic tail play a key role in sorting reovirus within the endocytic compartment. NPXY motifs are found in the cytoplasmic domains of many receptors (Chen et al. [@CR31_32]; Davis et al. [@CR44_32]; Oleinikov et al. [@CR108_32]) and recruit adaptor protein 2 or disabled protein 2 (Morris and Cooper [@CR99_32]; Oleinikov et al. [@CR108_32]) to initiate clathrin assembly at the plasma membrane. Substitution of a tyrosine with a phenylalanine residue in either or both β1 integrin NPXY motifs (NPXF) results in inefficient internalization of reovirus virions and diminished infectivity (Maginnis et al. [@CR89_32]). Infection of cells expressing NPXF β1 integrin results in distribution of virions to lysosomes where they are degraded, suggesting that the β1 integrin NPXY motifs target reovirus to the precise endocytic organelle that permits functional disassembly. Cellular signaling networks that respond to reovirus and facilitate its uptake and endocytic transport are unknown.

Removal of Outer-Capsid Protein σ3 by Cathepsin Proteases Initiates the Reovirus Disassembly Cascade {#Sec5}
====================================================================================================

In cellular endosomes, reovirus virions undergo stepwise disassembly to form discrete intermediates, the first of which is the ISVP (Borsa et al. [@CR15_32]; Chang and Zweerink [@CR25_32]; Silverstein et al. [@CR123_32]; Sturzenbecker et al. [@CR130_32]) (Figs. [1](#Fig1){ref-type="fig"} and [4](#Fig4){ref-type="fig"}). ISVPs are characterized by the loss of σ3, a conformational change in σ1, and cleavage of μ1 to form δ and φ. The rate-limiting step in reovirus disassembly is the proteolytic removal of σ3 (Baer and Dermody [@CR5_32]; Sturzenbecker et al. [@CR130_32]). Proteolysis of σ3 is dependent on acidic pH in some cell types (Dermody et al. [@CR46_32]; Sturzenbecker et al. [@CR130_32]) and endocytic cysteine proteases (Baer and Dermody [@CR5_32]). Cathepsins B and L catalyze reovirus disassembly in fibroblasts (Ebert et al. [@CR53_32]). Both enzymes are optimally active at acidic pH and serve functions in extracellular matrix formation, antigen presentation, and apoptosis (Chapman et al. [@CR26_32]). These enzymes also mediate cell entry of several other viruses, including Ebola virus (Chandran et al. [@CR24_32]), Hendra virus (Pager and Dutch [@CR111_32]), and SARS coronavirus (Huang et al. [@CR75_32]). Cathepsin S, a neutral pH cysteine protease required for processing internalized antigens (Riese et al. [@CR116_32]), mediates uncoating of some reovirus strains in a macrophage cell line (Golden et al. [@CR64_32]). It is possible that the broad tissue tropism displayed by reovirus is determined in part by the multiple host proteases capable of mediating its disassembly, analogous to highly pathogenic influenza viruses that disseminate systemically by utilization of alternative proteases for hemagglutinin processing (Goto and Kawaoka [@CR65_32]; Stieneke-Grober et al. [@CR127_32]).

Proteolytic enzymes also are required for reovirus infection following peroral inoculation of mice (Bass et al. [@CR11_32]; Bodkin et al. [@CR13_32]). Reovirus virions are converted to ISVPs in the intestinal lumen by the resident serine proteases chymotrypsin and trypsin. ISVPs produced in this fashion infect intestinal M cells to allow systemic dissemination of reovirus in the host (Amerongen et al. [@CR3_32]). ISVPs generated by chymotrypsin or trypsin *in vitro* or in the gut lumen (Bass et al. [@CR11_32]; Bodkin et al. [@CR13_32]) are indistinguishable from ISVPs generated by cathepsin B or cathepsin L *in vitro* or in the endocytic compartment of cells (Baer et al. [@CR6_32]; Ebert et al. [@CR53_32]).

Sequences in σ3 that influence its susceptibility to proteolysis have been identified through studies of viruses selected during persistent infection (PI viruses) or mutant viruses selected for resistance to either cysteine protease inhibitor E64 (D-EA viruses) (Ebert et al. [@CR52_32]) or ammonium chloride (ACA-D viruses) (Clark et al. [@CR32_32]). These viruses exhibit accelerated kinetics of disassembly and harbor a Tyr→His mutation at amino acid 354 near the C-terminus of the protein (Clark et al. [@CR32_32]; Ebert et al. [@CR52_32]; Wetzel et al. [@CR147_32]) (Fig. [6](#Fig6){ref-type="fig"}). Cryo-EM image analysis of a PI virus with an isolated Y354H mutation reveals a structural alteration in σ3 at a hinge region located between its two major domains (Wilson et al. [@CR150_32]). These findings suggest that the C-terminus of σ3 regulates susceptibility of the protein to cleavage.Fig. 6The σ3 protein is a target for cathepsin proteolysis. (**a**) The primary amino acid sequence of σ3 from amino acids 241 to 255 is shown. *Arrows* highlight cathepsin L cleavage sites identified by N-terminal sequencing of σ3 cleavage products following treatment of reovirus strain T1L with cathepsin L *in vitro*. (**b**) Cathepsin L cleavage sites are highlighted in the crystal structure of σ3. A ribbon diagram of the crystal structure of T3D σ3 (Olland et al. [@CR109_32]) is displayed on the *left*. The cathepsin L cleavage sites in T1L are depicted in *blue* between amino acids 243 and 244 and between 250 and 251. Surrounding residues, from amino acids 241 to 253, are shown in *yellow*. The C-terminal residues of σ3, from amino acids 340 to 365, are colored *red*. Amino acid 354, which is altered in PI, D-EA, and ACA-D viruses, is colored *green*. The virion-distal end of σ3 is at the *top* of the figure, and the virion-proximal end and N-terminus are at the *bottom*. (**c**) An enlarged view of the boxed region of σ3 indicated in panel B is shown using the same color scheme. Amino acids 243, 244, 250, 251, and 354 are depicted in ball-and-stick representation. Figure and legend modified from Ebert et al. ([@CR53_32])

The σ3 C-terminus also dictates strain-specific differences in the susceptibility of σ3 to proteolytic attack (Jané-Valbuena et al. [@CR78_32], [@CR79_32]). The σ3 protein of strain T1L is cleaved more rapidly than that of T3D. Analysis of ISVPs recoated with chimeric σ3 proteins generated from T1L and T3D revealed that the C-terminus is primarily responsible for the rate of σ3 proteolysis. Moreover, sequence polymorphisms at residues 344, 347, and 353 in σ3 contribute to this effect (Jané-Valbuena et al. [@CR79_32]).

Treatment of reovirus virions *in vitro* with either cathepsin B or cathepsin L leads to an initial cleavage of σ3 at a terminus (Ebert et al. [@CR53_32]). Since sequence polymorphisms in the σ3 C-terminus determine susceptibility to proteolysis, the initial cleavage of σ3 probably occurs in this region. During proteolysis by cathepsin L, subsequent cleavages occur between residues 243--244 and 250--251 (Ebert et al. [@CR53_32]) (Fig. [6](#Fig6){ref-type="fig"}a). These cleavage sites are physically located near the C-terminus in the σ3 crystal structure (Olland et al. [@CR109_32]) (Fig. [6](#Fig6){ref-type="fig"}b, c). Because of this proximity, the small end fragment released following initial cathepsin L cleavage likely exposes the cleavage sites between residues 243--244 and 250--251, rendering them sensitive to proteolysis. The C-terminus therefore appears to control access to internal, proteolytically sensitive sites in σ3. Because reovirus disassembly in some cell types is acid-dependent (Dermody et al. [@CR46_32]; Sturzenbecker et al. [@CR130_32]), the C-terminus might be primed for movement at acidic pH. Mutations near the C-terminus, like Y354H, may alter the conformation of the protein to allow improved access to these cleavage sites and thus accelerate outer capsid disassembly (Wilson et al. [@CR150_32]). High-resolution structural analysis of Y354H-σ3, which is currently ongoing, will enhance an understanding of σ3 proteolysis.

Penetration of Endosomal Membranes by Reovirus Is Mediated by Outer-Capsid Protein μ1 {#Sec6}
=====================================================================================

Studies to assess the capacity of reovirus entry intermediates to penetrate artificial lipid bilayers, model membranes of erythrocytes, or membranes of cells that support reovirus infection indicate that ISVPs but not virions or cores mediate membrane penetration (Borsa et al. [@CR14_32]; Chandran and Nibert [@CR19_32]; Chandran et al. [@CR20_32], [@CR21_32]; Hooper and Fields [@CR74_32]; Lucia-Jandris et al. [@CR85_32]; Tosteson et al. [@CR134_32]). Such studies led to the idea that ISVPs or a related subviral particle is the membrane-active intermediate in the reovirus entry pathway. Since ISVPs differ from cores by the presence of outer-capsid proteins σ1 and μ1 (Coombs [@CR39_32]; Dryden et al. [@CR49_32]), and because cores recoated *in vitro* with μ1 alone are capable of membrane penetration (Chandran et al. [@CR20_32]), these findings point to a role for the μ1 protein in membrane penetration. This biochemical evidence is also supported by several genetic studies. Differences in membrane-penetration efficiency displayed by reovirus strains T1L and T3D segregate with the μ1-encoding M2 gene segment (Chandran et al. [@CR22_32]; Lucia-Jandris et al. [@CR85_32]). Additionally, viruses selected for resistance to denaturants such as ethanol contain mutations within the M2 gene segment and display alterations in membrane penetration capacity (Chandran et al. [@CR22_32]; Danthi et al. [@CR43_32]; Hooper and Fields [@CR74_32]; Wessner and Fields [@CR146_32]). Together, these data demonstrate a function for the μ1 protein in membrane penetration.

The μ1 protein folds into four distinct domains (Fig. [7](#Fig7){ref-type="fig"}a). Domains I, II, and III are primarily α-helical and show no homology with other proteins. Domain IV forms a jelly-roll β-barrel commonly found in the capsid proteins of many nonenveloped viruses (Harrison [@CR70_32]). This domain interacts extensively with similar domains of the neighboring μ1 molecules and with σ3. The μ1 protein also contains three proteolytic cleavage sites (Fig. [7](#Fig7){ref-type="fig"}b). These include an autocatalytic cleavage site at amino acid 42, which separates μ1N and μ1C, a cleavage site at approximately amino acid 580, which releases the δ and φ fragments, and a cleavage site at the C-terminus that releases an ∼10 amino acid peptide (Chandran et al. [@CR23_32]; Mendez et al. [@CR94_32]; Nibert and Fields [@CR102_32]; Odegard et al. [@CR107_32]). While the physiologic roles of both the δ--φ and the C-terminal cleavages are unclear, studies using reovirus cores recoated with a μ1N--μ1C cleavage-resistant μ1 mutant indicate that cleavage of μ1 to generate μ1N and μ1C is required for membrane penetration and virion infectivity (Odegard et al. [@CR107_32]). Since μ1N is released from viral particles, it is postulated that cleavage of μ1 is required for release of μ1N, which then interacts with membranes as a function of its myristate moiety to effect membrane penetration (Ivanovic et al. [@CR77_32]). The requirement for the release of a small hydrophobic peptide for membrane penetration is strikingly similar to the entry mechanisms employed by other nonenveloped viruses such as adenoviruses (Wiethoff et al. [@CR148_32]), nodaviruses (Schneemann et al. [@CR121_32]; Walukiewicz et al. [@CR143_32]), and picornaviruses (Danthi et al. [@CR40_32]).Fig. 7The μ1 protein mediates membrane penetration. (**a**) Ribbon diagram of the crystal structure of the T1L μ1 trimer without bound σ3. One μ1 subunit is colored by domain (domain I, *light* and *dark blue* \[μ1N, μ1C\]; domain II, *light* and *dark green* \[μ1N, μ1C\]; domain III, *red*; domain IV, *yellow*); the other two μ1 subunits are shown in *gray*. The β-octyl glucosides and sulfate ions present in the structure are shown in *red* and *yellow*. (**b**) Domain segmentation of the amino acid sequence as determined from the three-dimensional structure. The domain color code is as depicted in (a). Cleavage sites are indicated by *arrows*. Figure modified from Liemann et al. ([@CR84_32]). (**c** and **d**) A 3% v/v solution of bovine erythrocytes was incubated with 5.4 × 10^10^ ISVPs of wild-type rsT3D or the indicated μ1 δ (c) or μ1 φ (d) mutant at 37°C for 1 h. Hemolysis was quantified by determining absorbance of the supernatant at 415 nm. Hemolysis following treatment of an equal number of cells with virion-storage buffer or virion-storage buffer containing 1% TX-100 was considered to be 0 or 100%, respectively. Results are expressed as mean percent hemolysis for triplicate samples. *Error bars* indicate SD. \*, *P* \< 0.05 as determined by Student's *t-*test in comparison to rsT3D. Figure modified from Danthi et al. ([@CR42_32], [@CR43_32])

In the native μ1 structure present in virions and ISVPs, the myristoylated μ1N fragment is buried inside a hydrophobic cavity in the α-helical pedestal formed by portions of domains I, II, and III (Liemann et al. [@CR84_32]; Zhang et al. [@CR154_32]). Based on these studies, massive conformational rearrangements resulting in unwinding of the μ1 trimer must be required to release μ1N during cell entry (Liemann et al. [@CR84_32]; Zhang et al. [@CR155_32]). Evidence for conformational changes in particle-associated μ1 following interaction of ISVPs with membranes or when exposed to high salt concentrations has led to the identification of an ISVP-like entry intermediate in the reovirus cell entry pathway (Chandran et al. [@CR22_32]). This intermediate, referred to as ISVP\*, is characterized by changes in the conformation of the μ1 δ fragment, loss of the σ1 protein, and an increase in the overall hydrophobicity of the particle (Chandran et al. [@CR22_32]). Thus, the μ1 protein associated with ISVPs is in a metastable state primed to undergo conformational changes to assume a more hydrophobic structure capable of interaction with membranes. While it is not understood how these conformational changes in μ1 are triggered, it is thought that interaction of an anion-binding site in domain IV with phospholipid head groups in endosomal membranes might trigger the requisite rearrangements in μ1 that reveal the myristoylated μ1N and the internal hydrophobic residues (Liemann et al. [@CR84_32]). At high particle concentrations, ISVP\* conversion is regulated by a positive feedback mechanism in which μ1N, which is released during ISVP\* formation, promotes ISVP-to-ISVP\* conversion of the remaining particles (Agosto et al. [@CR2_32]). Acceleration of ISVP\* formation by μ1N is dependent on temperature and target flexibility, suggesting that particle dynamics are required to expose a μ1N interaction domain (Agosto et al. [@CR2_32]). Since such particle concentrations are unlikely to be achieved following a low multiplicity viral infection, it remains unclear how these findings translate to ISVP\* formation in cellular endosomes during viral entry.

Genetic studies using ethanol-resistant or thermostable mutants indicate that μ1 residues affecting the overall stability of the virus also regulate membrane-penetration efficiency (Chandran et al. [@CR22_32]; Danthi et al. [@CR43_32]; Hooper and Fields [@CR74_32]; Wessner and Fields [@CR146_32]). These and other stability-altering residues identified in thermostable reovirus mutants (Middleton et al. [@CR97_32]) are located between residues 383 and 612 of μ1 and map to either domain IV that forms the jelly-roll β-barrel or the α-helical portions of domain III that lie just below the β-barrel structure. Since these μ1 domains participate in interactions between neighboring μ1 monomers, these residues are thought to modulate viral stability by preventing unwinding of the μ1 trimer (Liemann et al. [@CR84_32]). Consistent with an increase in μ1 protein rigidity in ethanol-resistant and thermostable mutants, viral cores recoated with mutant μ1 proteins, or recombinant reoviruses containing single amino acid substitutions in μ1 in an otherwise wild-type background, display diminished ISVP-to-ISVP\* conversion and have defects in membrane penetration (Wessner and Fields [@CR146_32]; Hooper and Fields [@CR74_32]; Chandran et al. [@CR22_32]; Middleton et al. [@CR97_32]; Danthi et al. [@CR42_32], [@CR43_32]) (Fig. [7](#Fig7){ref-type="fig"}c, d). These studies suggest that a central region of μ1 involved in intermolecular interactions is an important regulator of the ISVP-to-ISVP\* transition. In addition to these residues, changes in the C-terminal φ fragment also control viral stability (Middleton et al. [@CR97_32]) and affect membrane penetration by reducing the efficiency of ISVP-to-ISVP\* conversion (Danthi et al. [@CR42_32]). While it is not clear how φ residues modulate these properties, since both μ1N and φ are released from the virus particle during ISVP\* formation (Ivanovic et al. [@CR77_32]), it is likely that conformational rearrangements in μ1 during ISVP\* formation are not restricted to the δ domain but also involve the μ1N and φ domains. Therefore, amino acid substitutions within φ that negatively affect its conformational flexibility would likely prevent the μ1 reorganization required for ISVP\* formation. Biochemical and structural characterization of additional mutant viruses that may be affected to varying degrees in the capacity to undergo μ1 conformational changes may identify as yet unknown intermediates during ISVP-to-ISVP\* conversion and offer insights into mechanisms that promote the elaborate remodeling of μ1 required for membrane penetration.

Analogous to the picornaviruses (Danthi et al. [@CR40_32]), reovirus forms small, size-selective pores in erythrocyte model membranes (Agosto et al. [@CR1_32]). Both μ1N and ISVP\*s associate with erythrocyte membranes (Agosto et al. [@CR1_32]; Ivanovic et al. [@CR77_32]), but μ1N is capable of pore formation in the absence of other viral components (Ivanovic et al. [@CR77_32]). While φ also associates with membranes (Ivanovic et al. [@CR77_32]), its recruitment does not result in membrane penetration. These findings are consistent with the observation that viruses incapable of δ--φ cleavage can penetrate membranes and are fully infectious (Chandran and Nibert [@CR19_32]; Chandran et al. [@CR20_32]). Since pore formation by μ1N is enhanced by the presence of φ, it is possible that φ functions as a μ1N chaperone and facilitates membrane penetration by reovirus (Ivanovic et al. [@CR77_32]). Pores formed by released μ1N fragments are considerably smaller than those required to allow the viral intermediate to traverse the membrane (Agosto et al. [@CR1_32]). Therefore, it is not clear how pore formation in model membranes relates to membrane penetration during cell entry. Analogous to erythrocyte membrane rupture, pore formation may result in osmotic lysis of endosomes in which viral particles are present. Alternatively, the initial small pore formed by the virus might recruit cellular factors that produce larger pores or channels through which the viral intermediate can translocate.

Both the viral core and the δ fragment of μ1 are found in the cytoplasm following reovirus entry into host cells (Chandran et al. [@CR23_32]). While δ is found distributed diffusely throughout the cytosol, viral cores display a more punctuate cytoplasmic localization (Chandran et al. [@CR23_32]). These observations suggest that the δ fragment disassociates from the ISVP\* either during or immediately after membrane penetration. This idea is supported by the evidence that reovirus cores are transcriptionally active in the cytoplasm and that activation of transcription requires complete removal of the μ1 fragments. Removal of δ from cores is thought to be accomplished by direct interaction of δ with the host chaperone Hsc70 via an ATP-dependent process (Ivanovic et al. [@CR76_32]). Based on the finding that chaperones can translocate proteins across membranes (Young et al. [@CR152_32]), it is possible that concomitant with removal of particle-associated δ, Hsc70 also aids in transport of the viral core across membranes (Ivanovic et al. [@CR76_32]). Additional experiments are required to reveal the precise mechanism by which host membranes are breached by reovirus.

Reovirus Entry Evokes Innate Immune Responses that Trigger Cell Death {#Sec7}
=====================================================================

Reovirus infection elicits apoptosis of cultured cells and *in vivo*. Apoptosis induction by reovirus requires activation of innate immune transcription factors NF-κB and IRF-3 (Connolly et al. [@CR37_32]; Hansberger et al. [@CR69_32]; Holm et al. [@CR73_32]) (Fig. [8](#Fig8){ref-type="fig"}). In cultured cells, reovirus-induced apoptosis does not require de novo synthesis of viral RNA and protein (Connolly and Dermody [@CR36_32]; Danthi et al. [@CR41_32]), indicating that the proapoptotic stimulus is contained within infecting viral capsids. Consistent with these findings, strain-specific differences in the capacity of reovirus to induce apoptosis segregate genetically with the viral S1 and M2 gene segments (Connolly et al. [@CR38_32]; Tyler et al. [@CR137_32], [@CR138_32]), which encode σ1 and μ1, respectively (McCrae and Joklik [@CR93_32]; Mustoe et al. [@CR101_32]). Antibody-dependent uptake of reovirus virions in an entry process that does not require JAM-A and SA leads to apoptotic cell death, indicating that signaling pathways triggered by σ1-receptor interactions are dispensable for reovirus-induced apoptosis (Danthi et al. [@CR41_32]). Regardless of the receptors used to mediate attachment, initiation of prodeath signaling following reovirus infection requires viral disassembly in cellular endosomes (Danthi et al. [@CR41_32]), suggesting an essential function for the μ1 protein in apoptosis induction.Fig. 8Reovirus entry triggers apoptosis dependent on NF-κB and IRF-3. (**a** and **b**) Wild-type cells or cells lacking NF-κB p50, NF-κB p65/RelA, or IRF-3 were either mock-infected or infected with T3D at an MOI of 100 PFU/cell. After incubation at 37°C for 48 h, cells were stained with acridine orange. The results are expressed as the mean percentage of cells undergoing apoptosis for three independent experiments. *Error bars* indicate SD. \*, *P* \< 0.05 as determined by Student's *t*-test in comparison to T3D-infected wild-type cells. Figure modified from Connolly et al. ([@CR37_32]) and Holm et al. ([@CR73_32]). (**c** and **d**) HeLa cells were infected with rsT3D or each μ1 δ (c) or μ1 φ (d) mutant at an MOI of 100 PFU/cell. Following 48 h incubation, the percentage of apoptotic cells was determined by staining with acridine orange. Results are expressed as the mean percentage of apoptotic cells for triplicate samples. *Error bars* indicate SD. \*, *P* \< 0.05 as determined by Student's *t*-test in comparison to rsT3D. Figure modified from Danthi et al. ([@CR42_32], [@CR43_32])

Introduction of single amino acid substitutions into the δ region of μ1 decreases the capacity of the resultant mutant viruses to effect membrane penetration, mobilize NF-κB, and evoke apoptosis (Danthi et al. [@CR43_32]) (Fig. [8](#Fig8){ref-type="fig"}c). These findings suggest that the membrane-penetration and apoptosis induction-functions of μ1 are linked and that the δ region of μ1 is an essential modulator of both processes (Danthi et al. [@CR43_32]). It is possible that membrane penetration directly initiates proapoptotic signals. Alternatively, membrane penetration might allow delivery of the μ1 cleavage fragments into the cytoplasm where prodeath signaling is elicited. Two lines of evidence support the latter possibility. First, plasmid-driven expression of the μ1 φ domain in the cytoplasm is sufficient to induce apoptosis (Coffey et al. [@CR35_32]). Second, recombinant viruses with engineered substitutions within φ are diminished in NF-κB activation and apoptosis (Danthi et al. [@CR42_32]) (Fig. [8](#Fig8){ref-type="fig"}d). Importantly, a membrane-penetration-proficient φ mutant is impaired in the capacity to activate prodeath signaling, indicating that φ modulates apoptosis independent of an effect on membrane penetration (Danthi et al. [@CR42_32]). Based on these findings, it appears likely that cytoplasmic delivery of φ subsequent to membrane penetration initiates prodeath signaling following reovirus infection (Danthi et al. [@CR42_32]).

IRF-3 activation following reovirus infection requires the RIG-I pathogen sensor and the IPS-1 adaptor protein (Holm et al. [@CR73_32]). Interestingly, unlike other viral systems, these host proteins are dispensable for reovirus-induced NF-κB activation (Holm et al. [@CR73_32]). Since activation of IRF-3 also does not require viral RNA synthesis and occurs during viral entry, it is thought that viral genomic dsRNA triggers these signaling pathways (Holm et al. [@CR73_32]). Empty reovirus particles devoid of genome can stimulate NF-κB but not IRF-3, providing additional support for the idea that NF-κB and IRF-3 are activated following reovirus infection via distinct mechanisms (Connolly et al. [@CR37_32]; Holm et al. [@CR73_32]). Since reovirus empty particles are capable of eliciting apoptosis (Connolly and Dermody [@CR36_32]) but do not lead to IRF-3 activation (Holm et al. [@CR73_32]), IRF-3 appears to play a contributory but nonessential role in reovirus-induced apoptosis. Precise mechanisms by which the products of reovirus disassembly activate innate immune response signaling networks are unknown.

Conclusions and Future Directions {#Sec8}
=================================

The process of cell entry is poorly understood for many pathogenic viruses. This gap in knowledge has been a significant impediment to the rational design of antiviral agents and vaccines that target distinct steps in the entry process. Studies of mammalian reovirus have uncovered discrete attachment and internalization receptors, a function for cathepsin proteases in disassembly, an intricate mechanism for protein-membrane interactions, and a framework for activation of innate immune response signaling. Many of these functions are shared by other viral pathogens, suggesting conserved mechanisms of cell entry that should be amenable to common therapeutic approaches. However, there is much more to learn.

The current model of σ1-JAM-A interactions at the cell surface suggests that structural characteristics of σ1 may facilitate concurrent engagement of JAM-A and carbohydrates by appropriately positioning the receptor-binding domains. Indeed, studies of adenovirus fiber, which is structurally homologous to σ1 (Stehle and Dermody [@CR125_32]), have highlighted the importance of length and flexibility in viral tropism (Wu et al. [@CR151_32]). However, the contributions of σ1 length and flexibility to reovirus receptor engagement have not been explored. In the structure of a σ1-JAM-A complex, the σ1 head forms a trimer. Yet, there is evidence to suggest that σ1 may at times exist in a partially detrimerized conformation (Fraser et al. [@CR58_32]; Schelling et al. [@CR119_32]). An improved understanding of the role of the unusual aspartic acid sandwich trimerization motif may lend insight into the contributions of trimer instability to reovirus attachment and entry.

Reovirus serotypes display striking differences in pathogenesis that are directly linked to σ1 (Tyler et al. [@CR136_32]; Weiner et al. [@CR144_32], [@CR145_32]). However, each of the reovirus serotypes uses JAM-A as a receptor (Campbell et al. [@CR17_32]). Considering previous studies of reovirus interactions with JAM-A and carbohydrates, we think there are three possible explanations of σ1-mediated serotype-specific differences in reovirus tropism and disease. First, the carbohydrate specificity of a particular strain of reovirus might direct infection to specific cells or tissues. In support of this idea, serotype 3 reovirus strains that vary in SA utilization also vary in disease pathogenesis in the hepatobiliary system (Barton et al. [@CR10_32]). While there is some evidence that T1L binds SA in intestinal loops (Helander et al. [@CR71_32]), the exact nature of the carbohydrate coreceptors used by reovirus serotypes 1 and 2 remains undefined. Second, variations in the interaction kinetics or affinity of a particular σ1 serotype for JAM-A might contribute to differences in tropism. While there is overlap among JAM-A residues required for reovirus T1L, T2J, and T3D binding, there is evidence that the binding sites in JAM-A for these viruses differ (Guglielmi et al. [@CR68_32]). Furthermore, sequence alignments reveal that the residues in T3D σ1 that contact JAM-A in the complex (Kirchner et al. [@CR81_32]) are not entirely conserved among reoviruses of all serotype (Campbell et al. [@CR17_32]; Chappell et al. [@CR30_32]). On a cell that expresses only low levels of JAM-A, differences in receptor interaction kinetics or affinity might determine whether or not reovirus can initiate infection. Third, JAM-A might serve as a serotype-independent reovirus receptor at some sites within the host, and other, as yet unidentified, receptors confer serotype-dependent tropism in the central nervous system. Indeed, studies using non-SA-binding reovirus to infect JAM-A-null mice provide support for this hypothesis and point specifically to the existence of unidentified receptors in both the intestine and the central nervous system (Antar et al. [@CR4_32]). Future exploration of each of these possibilities will help clarify the role of σ1 in reovirus pathogenesis.

Internalization of reovirus requires β1 integrin (Maginnis et al. [@CR88_32]), but it is not known whether reovirus directly engages β1 integrin to initiate internalization or induces interactions between JAM-A (or other receptors) and β1 integrin to activate the uptake machinery. Furthermore, it is unclear whether activation of signaling pathways is required to trigger reovirus internalization by β1 integrin. Studies using mutant β1 integrin constructs suggest that NPXY motifs within β1 integrin direct transport of reovirus to the subcellular compartment for disassembly and membrane penetration (Maginnis et al. [@CR89_32]). However, the composition of the endocytic machinery recruited by the NPXY motifs that directs reovirus to the appropriate endocytic organelle for disassembly is yet to be identified. Since early steps in reovirus replication influence several stages of reovirus--host interactions (Virgin et al. [@CR142_32]), it is possible that engagement of β1 integrin influences reovirus pathogenesis. However, a function for β1 integrin in reovirus disease is unproven.

Disassembly of reovirus, which results in proteolytic removal of the σ3 outer-capsid protein, is essential for exposure of the viral membrane-penetration apparatus. While this process must be precisely controlled to ensure efficient infection, mechanisms that underlie this regulation are not understood. It is not known whether the low pH environment of the endocytic compartment is merely required for optimal activity of endocytic proteases that catalyze reovirus disassembly or also functions to trigger the conformational changes in σ3 that lead to its degradation. The σ3 protein contains multiple cathepsin protease cleavage sites that may be sequentially employed to facilitate its timely removal (Ebert et al. [@CR53_32]). However, it is not known whether a temporal pattern of cleavage site utilization exists for σ3. Cathepsins B and L are expressed in the intestine, liver, heart, and brain (Turk et al. [@CR135_32]), which serve as sites for reovirus infection in newborn mice (Barton et al. [@CR10_32]; O'Donnell et al. [@CR105_32]). Cathepsin S is largely restricted to cells and tissues of the immune system (Chapman et al. [@CR26_32]), which may influence reovirus replication in Peyer's patches during enteric infection (Fleeton et al. [@CR56_32]; Morrison et al. [@CR100_32]). Definition of cathepsin function in reovirus pathogenesis awaits the results of ongoing studies of reovirus infection using cathepsin-deficient mice.

Recent studies have provided important insights into mechanisms by which reovirus mediates membrane penetration. While a few residues within μ1 δ and φ that regulate conformational changes required for membrane penetration have been identified by analysis of mutant viruses (Chandran et al. [@CR22_32]; Danthi et al. [@CR42_32], [@CR43_32]), it is not known how the conformational alterations of the membrane-penetration apparatus liberate μ1N, which mediates membrane penetration (Ivanovic et al. [@CR77_32]). Additionally, the domains of μ1 reorganized during disassembly are only partially identified. The mechanism by which interaction of μ1N with the membrane results in pore formation and how its pore-forming capacity is enhanced by its interaction with φ also remain to be elucidated (Agosto et al. [@CR1_32]; Ivanovic et al. [@CR77_32]). Finally, it is not apparent how formation of small pores in membranes results in translocation of the reovirus core across the membrane.

Early steps in reovirus infection activate innate immune response transcription factors NF-κB and IRF-3 (Connolly et al. [@CR37_32]; Holm et al. [@CR73_32]), which drive the apoptotic response following reovirus infection (Connolly et al. [@CR37_32]; Hansberger et al. [@CR69_32]; Holm et al. [@CR73_32]; O'Donnell et al. [@CR106_32]). The activation of NF-κB is modulated by the μ1 φ domain subsequent to membrane penetration (Danthi et al. [@CR42_32]). However, the precise mechanism by which μ1 φ evokes NF-κB activation is unclear. Neither the fate of the φ fragment following entry of reovirus into host cells nor the cellular sensors that detect φ to trigger the prodeath function of NF-κB is known. Activation of IRF-3 following reovirus infection is dependent on the recognition of viral genomic dsRNA by RIG-I and IPS-1 (Holm et al. [@CR73_32]), but how the genomic dsRNA escapes from the viral core for detection by RIG-I is not evident.

In addition to enhancing an understanding of fundamental aspects of entry mechanisms employed by nonenveloped viruses, studies of reovirus cell entry are also pertinent to the development of optimal reovirus-based oncolytic and vaccine vectors. Reovirus infects transformed cells much more efficiently than it does nontransformed cells (Duncan et al. [@CR51_32]). Based on initial success in using reovirus for tumor killing in animal models (Coffey et al. [@CR34_32]; Hirasawa et al. [@CR72_32]), reovirus is currently undergoing clinical trials as a virotherapeutic for aggressive and refractory human tumors (Stoeckel and Hay [@CR128_32]). Since reovirus undergoes primary replication in intestinal tissue with few or no symptoms in humans (Tai et al. [@CR131_32]) and is now amenable to genetic modification (Kobayashi et al. [@CR82_32]), it also is an excellent candidate for development of a multifunctional vaccine modality to elicit mucosal immunity. Therefore, understanding the precise mechanisms by which reovirus attaches to host cells and initiates an infectious cycle will allow reovirus to be strategically engineered to facilitate retargeting to distinct host cells or enhance the efficiency of cell entry for a variety of therapeutic applications.
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